Literature DB >> 23483190

Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.

Xin Zheng1, Xiaohong Gai, Zhenhua Wu, Qingguang Liu, Yingmin Yao.   

Abstract

Hepatocellular carcinoma (HCC) is a common malignant cancer worldwide characterized by high metastatic potential and poor prognosis following radical resection. Metastasin is a Ca(2+)-binding protein associated with tumor metastasis. However, the expression and function of metastasin remain unknown. In the present study, we found that the expression of metastasin was upregulated in HCC tissues and positively correlated with poor prognosis following radical resection. Ectopic expression of metastasin in vitro induced typical epithelial-mesenchymal transition (EMT) in Hep3B cells including higher capacity of both migration and invasion, increased expression of both Vimentin and N-cadherin and decreased expression of E-cadherin. Knockdown of metastasin produced the opposite results in MHCC97H cells, which indicates that metastasin promotes HCC progression via induction of EMT. SNAI1 expression was upregulated by enforced expression of metastasin and, consequently, suppressing upregulation of SNAI1 secondary to metastasin overexpression abolished EMT. Collectively, the present results suggest that metastasin leads to HCC EMT partly through upregulating SNAI1 and contributes to poor prognosis following radical liver resection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23483190     DOI: 10.3892/or.2013.2341

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  7 in total

1.  HOXB9 promotes epithelial-to-mesenchymal transition via transforming growth factor-β1 pathway in hepatocellular carcinoma cells.

Authors:  Lin Sha; Lei Dong; Li Lv; Lizhi Bai; Xuening Ji
Journal:  Clin Exp Med       Date:  2014-08-01       Impact factor: 3.984

2.  High expression of S100A12 on intratumoral stroma cells indicates poor prognosis following surgical resection of hepatocellular carcinoma.

Authors:  Hao Cai; Bo-Gen Ye; Jian-Yang Ao; Xiao-Dong Zhu; Yuan-Yuan Zhang; Zong-Tao Chai; Cheng-Hao Wang; Hui-Chuan Sun
Journal:  Oncol Lett       Date:  2018-08-06       Impact factor: 2.967

3.  CtBP2 is an independent prognostic marker that promotes GLI1 induced epithelial-mesenchymal transition in hepatocellular carcinoma.

Authors:  Xin Zheng; Tao Song; Changwei Dou; Yuli Jia; Qingguang Liu
Journal:  Oncotarget       Date:  2015-02-28

4.  Caveolin-1 is up-regulated by GLI1 and contributes to GLI1-driven EMT in hepatocellular carcinoma.

Authors:  Xiaohong Gai; Zhongtang Lu; Kangsheng Tu; Zheyong Liang; Xin Zheng
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

5.  Monitoring Immune Checkpoint Regulators as Predictive Biomarkers in Hepatocellular Carcinoma.

Authors:  Ritu Shrestha; Prashanth Prithviraj; Matthew Anaka; Kim R Bridle; Darrell H G Crawford; Bijay Dhungel; Jason C Steel; Aparna Jayachandran
Journal:  Front Oncol       Date:  2018-07-13       Impact factor: 6.244

6.  Downregulation of ADAM10 expression inhibits metastasis and invasiveness of human hepatocellular carcinoma HepG2 cells.

Authors:  Yuan Yue; Yuan Shao; Qing Luo; Lei Shi; Zuoren Wang
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

7.  Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition.

Authors:  Tao Song; Cong Wang; Cheng Guo; Qingguang Liu; Xin Zheng
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.